Related Experiment Video
Updated: Aug 5, 2026
09:48
Intracortical Inhibition Within the Primary Motor Cortex Can Be Modulated by Changing the Focus of Attention
Published on: September 11, 2017
Piracetam affects facilitatory I-wave interaction in the human motor cortex
Summary
Piracetam, a GABA derivative, was studied using transcranial magnetic stimulation (TMS). A single dose reduced the size and latency of I-wave interaction peaks in healthy volunteers, suggesting novel neurological effects.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Piracetam is a GABA derivative with largely unknown mechanisms of action.
- Transcranial magnetic stimulation (TMS) allows investigation of intracortical excitability.
Purpose of the Study:
- To investigate the effect of a single oral dose of piracetam on intracortical facilitatory I-wave interaction using TMS.
- To explore potential GABAergic effects and novel phenomena related to piracetam's action.
Main Methods:
- 8 healthy volunteers received a 4000 mg oral dose of piracetam.
- Double-pulse TMS was used to elicit motor evoked potentials (MEPs) at various time points post-ingestion.
- I-wave interaction peaks were analyzed for changes in timing and size.
Main Results:
- Piracetam significantly reduced the size of I-wave interaction peaks.
- A significant shortening of I-wave peak latencies was observed 6 hours after piracetam intake.
- These effects showed partial reversibility after 24 hours.
Conclusions:
- Piracetam's peak size reduction resembles effects of GABAergic drugs, despite no previously known GABAergic properties.
- Shortened I-wave peak latencies represent a novel finding associated with piracetam.
- Results may inform understanding of piracetam's therapeutic effects in cortical myoclonus and its nootropic actions.
